Filter by Year: ALL 2022 2021 2020 2019 2018 2017 2015 Source FIERCE BIOTECH Merck teams up with cancer startup Foghorn in $425M deal July 8, 2020 Source ENDPOINTS NEWS Merck dangles up to $425 million to team with Flagship’s Foghorn Therapeutics on drugging the shape of DNA July 8, 2020 Source BIOSPACE Foghorn and Merck Ink Strategic Collaboration in Cancer for $425 Million+ July 8, 2020 Source BIOTECH 2050 Podcast Ep. 9 – Carl P. Decicco, PhD, Chief Scientific Officer, Foghorn Therapeutics January 23, 2020 Source WUXI APPTEC Innovation that Matters: Foghorn® Therapeutics’ Gene Traffic Control Product™ Platform October 30, 2019 Source XCONOMY Foghorn Therapeutics Adds Samuel Agresta, Allan Reine to C-Suite September 19, 2019 Source FIERCEBIOTECH Foghorn and Rgenix nab Agios, Roche veterans as new CMOs September 16, 2019 Source PHARMAVOICE CEO Adrian Gottschalk Named to PharmaVOICE 100 August 1, 2019 Source VENTURE CAPITAL HORIZONS REVISITING HEALTHCARE Foghorn Therapeutics: A pioneer in chromatin biology June 11, 2019 Source C&EN NEWS Foghorn Therapeutics takes aim at chromatin hijackers to stop cancer May 12, 2019 Previous 1 2 3 4 Next